Testicular cancer (testicular tubular cancer) is a malignant neoplasm that develops in the tissues of the testicles, which are responsible for the production of sperm and male sex hormones. This disease is most common in young men between the ages of 15 and 35, but can also occur at an older age. It is classified into two main groups: seminomas and non-seminomas. Seminomas are characterized by slow growth and a better prognosis, while non-seminomas can be more aggressive. These tumors may manifest with initial symptoms in the form of an enlarged testicle, pain, change in consistency or formation in the scrotum. Correct and timely diagnosis of testicular cancer is critical, as this disease can be effectively treated if detected early.
History of the disease and interesting historical facts
The history of testicular cancer goes back several centuries. The first descriptions of tumor diseases in the testicles date back to Ancient Egypt, where doctors recorded cases of enlarged testicles and suspected tumors. However, for a long time, testicular cancer was considered a rare disease, and only in the 20th century did its prevalence statistics begin to change. In the 1940s, doctors began actively researching testicular tumors, which led to an understanding of their biology and the development of modern treatment methods. For example, the introduction of the orchidectomy method (removal of the testicle) opened up new horizons for therapy, which significantly improved patient outcomes.
Epidemiology
According to current data, testicular cancer is one of the most common cancers among men aged 15 to 35 years. According to the World Health Organization, the incidence of this type of cancer varies depending on the geographical regions. The highest incidence rates are recorded in northern countries such as Sweden and Norway. Approximately 5-6 men out of 100,000 are diagnosed with this disease each year in Europe. It is important to note that the incidence among black men is significantly lower than among white and Jewish men. In recent decades, there has been a trend towards an increase in the incidence of testicular cancer, which may be due to improved diagnostic methods and changes in lifestyle.
Genetic predisposition to this disease
Research shows that genetic predisposition plays an important role in the development of testicular cancer. Having a family history of testicular disease increases the risk of developing the disease in future generations. Certain genetic mutations, such as mutations in the KIT and BAK1 genes, have been associated with an increased risk of developing testicular cancer. In addition, the presence of mutations in chromosome 12 opens up new horizons for genetic testing and risk prognosis. A number of studies also indicate that men with cryptorchidism (undescended testicle) have a significantly increased risk of developing testicular cancer, which confirms the link between endocrine and genetic factors.
Risk factors for the development of this disease
There are many risk factors that contribute to the development of testicular cancer. These include:
- Cryptorchidism is the failure of a testicle to descend into the scrotum, which increases the risk of disease by 10-40 times.
- Family history of testicular cancer - having close relatives with the disease significantly increases your chances of developing it.
- Endocrine disorders are abnormalities in the levels of sex hormones.
- Age - risk increases significantly at a young age, especially for men between 15 and 35 years of age.
- Chemical exposure - Certain chemicals and toxic agents may be associated with an increased risk of developing the disease.
- Presence of other medical conditions - having HIV/AIDS and other immunodeficiency conditions may increase the risk.
Diagnosis of this disease
Diagnosis of testicular cancer should be based on a systematic approach that includes:
- The main symptoms are: enlargement of the testicle, a feeling of heaviness in the scrotum, pain or the presence of a formation in the testicular area.
- Laboratory tests: determination of tumor markers such as alpha-fetoprotein (AFP), beta-hCG and LDH.
- Radiological examinations: Ultrasound of the scrotum is the first and most informative study that helps to visualize the tumor.
- Other diagnostic tests: CT scan and MRI can be used to assess the extent of the disease.
- Differential diagnosis: it is important to exclude conditions such as hydrocele, varicocele and infectious inflammatory processes.
Treatment
Treatment for testicular cancer involves several approaches, which may vary depending on the stage of the disease:
- General treatment: Orchiectomy (removal of the affected testicle) is the mainstay of treatment, especially in the early stages.
- Pharmacological treatment: Chemotherapy is used in case of metastatic cancer, where drugs such as platinum-containing compounds are used.
- Surgical treatment: In some cases, non-diabetic lymphadenectomy may be performed to remove the affected lymph nodes.
- Other treatments: Radiotherapy may be considered for seminomas, especially if there are lymph node metastases.
List of medications used to treat this disease
The main drugs used to treat testicular cancer include:
- Cisplatin
- etoposide
- Bleomycin
- Doxorubicin
- Paclitaxel
Disease monitoring
Monitoring patients with testicular cancer requires systematic assessment of health status and timely detection of recurrences. Control stages include:
- Regular medical examinations every 3 months for the first two years after treatment.
- Monitoring of tumor markers such as AFP and beta-hCG every two months during the first year.
- If the disease is detected early and treated correctly, it has a good prognosis - radical treatment makes it possible to achieve 95% survival.
- Complications may include lymphedema and secondary tumors, so medical supervision is important.
Age-related features of the disease
Testicular cancer has its own characteristics depending on the age category:
- Adolescents and young adults (15-35 years): highest risk, often with seminomas and aggressive forms of the disease.
- Middle-aged people (36-55 years): there is a higher risk of non-seminomas.
- Elderly people (over 55 years): characterized by less aggressive forms and lower incidence rates.
Questions and Answers
- What are the main symptoms of testicular cancer? The main symptoms include enlargement of one of the testicles, pain, a feeling of heaviness in the scrotum and the presence of a mass.
- How is testicular cancer diagnosed? Diagnosis includes physical examination, ultrasound of the scrotum, determination of tumor markers and computed tomography.
- What are the risk factors for developing testicular cancer? Major risk factors include cryptorchidism, positive family history, endocrine disorders, and chemical exposure.
- What is the treatment for testicular cancer? Treatment may include surgery, chemotherapy, and radiation therapy depending on the stage of the disease.
- What is the prognosis for testicular cancer? With early detection and adequate treatment, the prognosis remains favorable and reaches more than 95% survival.
